Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough ...

The ReFlow® EVD is the first device of its kind to provide a noninvasive, manual flushing mechanism designed to restore and maintain cerebrospinal fluid (CSF) flow. By reducing the risk of ...

("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from the FDA for its ReFlow® EVD, an innovative solution for external ...

Placing an external ventricular drain (EVD) at bedside using augmented reality (AR) guidance is more precise than freehand placement and is associated with fewer reinterventions and complications ...